#$%^&*AU2009243422B220120329.pdf#####ABSTRACT A pharmaceutical formulation which comprises azelastine, or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and mometasone or a pharmaceutically acceptable ester thereof. 21316061 (GHMatters) 30/11/09